Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu
- PMID: 12019156
Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu
Abstract
Expression of the mouse mammary tumor virus (MMTV) neu/erbB2 transgene in mice induces mammary tumors. To examine the effect of removing estrogen receptor alpha (ERalpha) signaling on the ability of an MMTV-neu/erbB2 transgene to induce mammary tumors, the neu transgene was expressed in the ERalpha knockout (alphaERKO) mouse, which lacks functional ERalpha. MMTV-neu females that lacked ERalpha still developed mammary tumors; however, tumor onset was significantly delayed. This study indicates that ERalpha is not required for mammary tumor induction by overexpression of neu/erbB2, but plays a role in the rate of tumor onset. The removal of ovarian steroid by ovariectomy in adults did not alter the onset rate. In contrast, prepubertal ovariectomy, which arrested mammary epithelial development, significantly delayed onset. In addition, manipulations that increase progesterone also accelerate the tumor onset, indicating the slower onset in the alphaERKO is primarily attributable to the anovulatory phenotype resulting in lack of progesterone stimulation and a decreased abundance of target cells in the alphaERKO mammary gland.
Similar articles
-
MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.Oncogene. 2001 Sep 20;20(42):6009-17. doi: 10.1038/sj.onc.1204830. Oncogene. 2001. PMID: 11593408
-
Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis.Cancer Res. 2004 May 15;64(10):3525-32. doi: 10.1158/0008-5472.CAN-03-3524. Cancer Res. 2004. PMID: 15150107
-
A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.Cancer Res. 1999 Apr 15;59(8):1869-76. Cancer Res. 1999. PMID: 10213494
-
Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.Biochem Soc Symp. 1998;63:159-65. Biochem Soc Symp. 1998. PMID: 9513720 Review.
-
Induction of a variety of preneoplasias and tumours in the mammary glands of transgenic rats.Biochem Soc Symp. 1998;63:167-84. Biochem Soc Symp. 1998. PMID: 9513721 Review.
Cited by
-
Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.Carcinogenesis. 2008 Dec;29(12):2252-8. doi: 10.1093/carcin/bgn214. Epub 2008 Sep 10. Carcinogenesis. 2008. PMID: 18784357 Free PMC article.
-
Expression of Human NSAID Activated Gene 1 in Mice Leads to Altered Mammary Gland Differentiation and Impaired Lactation.PLoS One. 2016 Jan 8;11(1):e0146518. doi: 10.1371/journal.pone.0146518. eCollection 2016. PLoS One. 2016. PMID: 26745373 Free PMC article.
-
Genetic control of ductal morphology, estrogen-induced ductal growth, and gene expression in female mouse mammary gland.Endocrinology. 2014 Aug;155(8):3025-35. doi: 10.1210/en.2013-1910. Epub 2014 Apr 7. Endocrinology. 2014. PMID: 24708240 Free PMC article.
-
Sex hormone receptor repertoire in breast cancer.Int J Breast Cancer. 2013;2013:284036. doi: 10.1155/2013/284036. Epub 2013 Nov 13. Int J Breast Cancer. 2013. PMID: 24324894 Free PMC article. Review.
-
Biological and biochemical consequences of global deletion of exon 3 from the ER alpha gene.FASEB J. 2010 Dec;24(12):4660-7. doi: 10.1096/fj.10-163428. Epub 2010 Jul 28. FASEB J. 2010. PMID: 20667977 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Research Materials
Miscellaneous